151 related articles for article (PubMed ID: 2854216)
1. Interactions of DPI 201-106, a novel cardiotonic agent, with cardiac calcium channels.
Siegl PK; Garcia ML; King VF; Scott AL; Morgan G; Kaczorowski GJ
Naunyn Schmiedebergs Arch Pharmacol; 1988 Dec; 338(6):684-91. PubMed ID: 2854216
[TBL] [Abstract][Full Text] [Related]
2. Binding of Ca2+ entry blockers to cardiac sarcolemmal membrane vesicles. Characterization of diltiazem-binding sites and their interaction with dihydropyridine and aralkylamine receptors.
Garcia ML; King VF; Siegl PK; Reuben JP; Kaczorowski GJ
J Biol Chem; 1986 Jun; 261(18):8146-57. PubMed ID: 2424894
[TBL] [Abstract][Full Text] [Related]
3. Interaction of tetrandrine with slowly inactivating calcium channels. Characterization of calcium channel modulation by an alkaloid of Chinese medicinal herb origin.
King VF; Garcia ML; Himmel D; Reuben JP; Lam YK; Pan JX; Han GQ; Kaczorowski GJ
J Biol Chem; 1988 Feb; 263(5):2238-44. PubMed ID: 2448307
[TBL] [Abstract][Full Text] [Related]
4. Interaction of the cardiotonic agent DPI 201-106 with cardiac Ca2+ channels.
Holck M; Osterrieder W
J Cardiovasc Pharmacol; 1988 Apr; 11(4):478-82. PubMed ID: 2453753
[TBL] [Abstract][Full Text] [Related]
5. Investigations of the mechanism of the positive inotropic action of BDF 9148: comparison with DPI 201-106 and the enantiomers.
Raap A; Armah B; Mest HJ; Stenzel W; Schloos J; Blechacz W
J Cardiovasc Pharmacol; 1997 Feb; 29(2):164-73. PubMed ID: 9057064
[TBL] [Abstract][Full Text] [Related]
6. Bis(benzylisoquinoline) analogs of tetrandrine block L-type calcium channels: evidence for interaction at the diltiazem-binding site.
Felix JP; King VF; Shevell JL; Garcia ML; Kaczorowski GJ; Bick IR; Slaughter RS
Biochemistry; 1992 Dec; 31(47):11793-800. PubMed ID: 1332772
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
[TBL] [Abstract][Full Text] [Related]
8. DPI 201-106, a novel cardioactive agent. Combination of cAMP-independent positive inotropic, negative chronotropic, action potential prolonging and coronary dilatory properties.
Scholtysik G; Salzmann R; Berthold R; Herzig JW; Quast U; Markstein R
Naunyn Schmiedebergs Arch Pharmacol; 1985 May; 329(3):316-25. PubMed ID: 2991779
[TBL] [Abstract][Full Text] [Related]
9. Reversal of the cardiotonic and action-potential prolonging effects of DPI 201-106 by BDF 8784, a methyl-indol derivative.
Armah BI; Pfeifer T; Ravens U
Br J Pharmacol; 1989 Apr; 96(4):807-16. PubMed ID: 2568142
[TBL] [Abstract][Full Text] [Related]
10. SR 33557, a novel calcium-antagonist: interaction with [3H]-(+/-)-nitrendipine and [3H]-(-)-desmethoxy-verapamil binding sites in cerebral membranes.
Nokin P; Clinet M; Polster P; Beaufort P; Meysmans L; Gougat J; Chatelain P
Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):31-6. PubMed ID: 2542806
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a distinct Ca2+ antagonist receptor for the novel benzothiazinone compound HOE 166.
Striessnig J; Meusburger E; Grabner M; Knaus HG; Glossmann H; Kaiser J; Schölkens B; Becker R; Linz W; Henning R
Naunyn Schmiedebergs Arch Pharmacol; 1988 Mar; 337(3):331-40. PubMed ID: 2839780
[TBL] [Abstract][Full Text] [Related]
12. Influence of Mg++ on the effect of diltiazem to increase dihydropyridine binding to receptors on Ca++-channels in chick cardiac and skeletal muscle membranes.
Maan AC; Ptasienski J; Hosey MM
J Pharmacol Exp Ther; 1986 Dec; 239(3):768-74. PubMed ID: 2432217
[TBL] [Abstract][Full Text] [Related]
13. Amiloride analogs inhibit L-type calcium channels and display calcium entry blocker activity.
Garcia ML; King VF; Shevell JL; Slaughter RS; Suarez-Kurtz G; Winquist RJ; Kaczorowski GJ
J Biol Chem; 1990 Mar; 265(7):3763-71. PubMed ID: 2154487
[TBL] [Abstract][Full Text] [Related]
14. Substituted diphenylbutylpiperidines bind to a unique high affinity site on the L-type calcium channel. Evidence for a fourth site in the cardiac calcium entry blocker receptor complex.
King VF; Garcia ML; Shevell JL; Slaughter RS; Kaczorowski GJ
J Biol Chem; 1989 Apr; 264(10):5633-41. PubMed ID: 2538426
[TBL] [Abstract][Full Text] [Related]
15. Calcium channel receptor binding studies for diltiazem and its major metabolites: functional correlation to inhibition of portal vein myogenic activity.
Schoemaker H; Hicks PE; Langer SZ
J Cardiovasc Pharmacol; 1987 Feb; 9(2):173-80. PubMed ID: 2435995
[TBL] [Abstract][Full Text] [Related]
16. Tissue response selectivity of calcium antagonists is not due to heterogeneity of [3H]-nitrendipine binding sites.
Bristow MR; Ginsburg R; Laser JA; McAuley BJ; Minobe W
Br J Pharmacol; 1984 Jun; 82(2):309-20. PubMed ID: 6329392
[TBL] [Abstract][Full Text] [Related]
17. Sialic acid removal modulates the myocardial and vascular activity of calcium channel ligands.
Werner G; Addicks K; Fricke U; Klaus W; Sarram M; Gielen W
Biochem Pharmacol; 1991 Dec; 42 Suppl():S77-87. PubMed ID: 1722670
[TBL] [Abstract][Full Text] [Related]
18. Evidence for different receptor sites for the novel cardiotonic S-DPI 201-106, ATX II and veratridine on the cardiac sodium channel.
Scholtysik G; Quast U; Schaad A
Eur J Pharmacol; 1986 Jun; 125(1):111-8. PubMed ID: 2426127
[TBL] [Abstract][Full Text] [Related]
19. Effects of hypoxia, elevated K+ and acidosis on the potency of verapamil, diltiazem and nifedipine in the guinea-pig isolated papillary muscle.
Robertson MJ; Lumley P
Br J Pharmacol; 1989 Nov; 98(3):937-49. PubMed ID: 2590774
[TBL] [Abstract][Full Text] [Related]
20. Relationship of binding of a calcium channel blocker to inhibition of contraction in intact cultured embryonic chick ventricular cells.
Marsh JD; Loh E; Lachance D; Barry WH; Smith TW
Circ Res; 1983 Oct; 53(4):539-43. PubMed ID: 6313249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
